Zoetis Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Zoetis Inc. on March 4, 2014. The report discloses a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a personnel appointment and associated compensation.
Material Changes
On March 4, 2014, the Board of Directors appointed Dr. Willie M. Reed to Class II of the Board. Dr. Reed is assigned to serve on the Corporate Governance Committee. There is no arrangement or understanding with any person pursuant to which Dr. Reed was appointed.
Compensation and Governance Details
In accordance with the Company's existing compensation policy for non-employee directors, Dr. Reed will receive:
- An annual cash retainer of $100,000.
- An annual equity retainer in the form of deferred stock units valued at $140,000.
The Company has also entered into its standard form of indemnification agreement with Dr. Reed.
Outlook, Risks, and Contingencies
The filing does not contain guidance, outlook, management commentary on operations, or discussions of risks and contingencies beyond the standard indemnification agreement.
Key Facts for Investor Verification
- Dr. Willie M. Reed was appointed to the Board of Directors on March 4, 2014.
- Dr. Reed will serve on the Corporate Governance Committee.
- Total annual compensation for the director role is $240,000 ($100,000 cash + $140,000 equity).
- No financial results or operational updates are included in this specific filing.